Few CROs offer compliant maintenance of the Trial Master File following study close closeout, usually returning the eTMF on unsecure and hard-to-track media such as USB drives or even printed out. These Trial Master Files are difficult to review and inspect, and force sponsors to keep their own study documents separate. Sponsors had limited options for compliance with regulatory requirements – until now.
The graphic below was inspired by an MHRA presentation from 2018 by Andy Fisher.
Note: Phlexglobal customers already have this capability as part of the PhlexTMF eTMF software.
In this session, we explore an innovative new way to ensure your TMF stays secure while remaining accessible to audits and inspectors so you can focus on getting your drug to market and not on finding documents.
| Usual Industry Approach | PhlexTMF for Viewing Provides | |
| TMF is often returned to sponsor on unsecure and hard-to-track media such as USB drives. |  |
Fully compliant, secure, cloud-based storage |
|
Many documents still printed out - even if the CRO is using an eTMF |
|
Easy for sponsors to review at any time from anywhere |
| Difficult for sponsors to review | |
Facilitates streamlined access for inspectors, which has become an expectation among regulatory agencies |
| Sponsor documents are typically separate | |
Sponsor documents can be added directly to PhlexTMF for Viewing |
Building the Right TMF Team for Inspection Readiness, Scalability and Growth As clinical trials become more complex, many Sponsors and CROs find themselves asking the same question: Do we need more
Why portfolio-level TMF oversight is becoming a necessity, not a luxury. The Problem With Thinking Study-by-Study Clinical trials do not happen in isolation. Sponsors and CROs are running multiple
How Senior TMF Study Owners bridge strategy, mentoring and operational delivery. What does it really mean to have an expert in your corner when it comes to your Trial Master File? For organisations